Location: Boston, MA
CIK: 0001703031 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $1.244B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $248M | 19.9% | $10.64 | +90.8% | ORDINARY SHARES | N62509109 |
| NUVL | NUVALENT INC | 2,697,267 | $203M | 16.3% | $28.96 | +174.8% | COM | 670703107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,992,028 | $89.76M | 7.2% | $21.73 | 0.0% | COM | 252828108 |
| IRON | DISC MEDICINE INC | 1,317,213 | $82.01M | 6.6% | $22.28 | +191.0% | COM | 254604101 |
| KYTX | KYVERNA THERAPEUTICS INC | 3,163,868 | $78.59M | 6.3% | $27.84 | 0.0% | COM | 501976104 |
| PHVS | PHARVARIS N V | 3,303,381 | $76.34M | 6.1% | $23.89 | +11.2% | COM | N69605108 |
| SVRA | SAVARA INC | 14,565,457 | $72.54M | 5.8% | $1.94 | +149.6% | COM | 805111101 |
| ANNX | ANNEXON INC | 8,703,268 | $62.4M | 5.0% | $11.24 | -53.8% | COM | 03589W102 |
| SLDB | SOLID BIOSCIENCES INC | 4,034,582 | $53.74M | 4.3% | $7.18 | +30.3% | COM NEW | 83422E204 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 196,995 | $52.61M | 4.2% | $174.99 | +34.7% | COM | 558868105 |
| — | MERSANA THERAPEUTICS INC | 8,663,673 | $38.81M | 3.1% | $12.65 | — | COM | 59045L106 |
| CABA | CABALETTA BIO INC | 1,617,364 | $27.59M | 2.2% | $10.85 | +97.7% | COM | 12674W109 |
| — | X4 PHARMACEUTICALS INC | 16,915,784 | $23.51M | 1.9% | $2.56 | — | COM | 98420X103 |
| TNGX | TANGO THERAPEUTICS INC | 2,892,663 | $22.97M | 1.8% | $10.01 | +7.1% | COM | 87583X109 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,011,687 | $19.94M | 1.6% | $26.87 | -72.2% | COM | 03969K108 |
| NRIX | NURIX THERAPEUTICS INC | 1,132,397 | $16.65M | 1.3% | $21.10 | -49.0% | COM | 67080M103 |
| SYRS | SYROS PHARMACEUTICALS INC | 2,749,808 | $14.71M | 1.2% | $5.62 | +23.0% | COM NEW | 87184Q206 |
| — | MARINUS PHARMACEUTICALS INC | 1,393,380 | $12.6M | 1.0% | $15.48 | — | COM NEW | 56854Q200 |
| AVIR | ATEA PHARMACEUTICALS INC | 2,485,638 | $10.04M | 0.8% | $32.23 | -87.9% | COM | 04683R106 |
| CCCC | C4 THERAPEUTICS INC | 1,142,210 | $9.332M | 0.7% | $29.00 | -73.3% | COM STK | 12529R107 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 8,434,560 | $8.182M | 0.7% | $20.66 | -95.3% | CLASS A COM | 75340L104 |
| IVVD | INVIVYD INC | 1,799,595 | $7.99M | 0.6% | $37.11 | -88.9% | COM | 00534A102 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5.88M | 0.5% | $10.83 | -73.8% | COM | 63909J108 |
| ACRS | ACLARIS THERAPEUTICS INC | 3,000,000 | $3.72M | 0.3% | $12.42 | -90.4% | COM | 00461U105 |
| XLO | XILIO THERAPEUTICS INC | 2,805,413 | $3.03M | 0.2% | $17.03 | -96.0% | COM | 98422T100 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.104M | 0.1% | $0.86 | — | *W EXP 99/99/999 | N62509117 |